Eye on OCT™ by Carl Zeiss is an online news and educational resource for clinicians with an interest in ophthalmic OCT. It highlights physician experiences, clinical reports, peer-reviewed journal articles, news, and educational tools related to ophthalmic OCT applications and instrumentation.
This site is powered by the technology of HiveFire, a Boston-based startup out of MIT. HiveFire's technology scours thousands of online sources using natural language processing and machine learning, enabling Carl Zeiss to deliver relevant information on OCT to current customers and subject area experts on a daily basis. For more information on HiveFire, please visit www.hivefire.com.
If you have suggestions on how to improve the site, or wish to submit an article, case report, video, or image, please contact the Editors of Eye on OCT.
Carl Zeiss was the first to commercialize OCT technology for ophthalmology, pioneering this market in 1995. In 2002, Carl Zeiss Meditec introduced Stratus OCT™, which became a gold standard product with more than 8,000 units in the marketplace today. The largest body of OCT clinical data, including a library of more than 2,000 peer reviewed articles, has been published about Stratus OCT™ to date. In 2007, Carl Zeiss Meditec launched Cirrus™ HD-OCT, the first in its category to deliver high-definition 3D maps. Today, Cirrus HD-OCT is the best selling ophthalmic spectral domain system and has become the modern OCT standard.
Carl Zeiss Meditec is one of the world’s leading medical technology companies. The company offers complete solutions, including implants and consumables, to diagnose and treat ophthalmic diseases. In the field of microsurgery the company provides innovative visualization solutions. Carl Zeiss Meditec's medical technology portfolio is rounded off by promising future technologies such as intraoperative radiotherapy.